Indeed, the aggregation/fibrillation of FUS and TDP-43 has been extensively demonstrated to be involved in “gain-of-toxicity” for ALS/FTD pathogenesis6–8,35–44. The gene discussed is FUS; the disease is frontotemporal dementia.